MomGuard NIPT is an advanced prenatal screening test designed to provide comprehensive insight and reassurance for expectant parents. The test analyzes all 23 pairs of chromosomes to screen for Down syndrome and other genetic abnormalities.
Samples are processed in South Korea using Next Generation Sequencing (NGS) technology on the ILLUMINA platform from the United States, ensuring high accuracy and reliability. The laboratory performing the analysis is accredited by the College of American Pathologists (CAP), USA, reflecting internationally recognized standards of quality and laboratory excellence.
9 Mar 2026
